Focus on the Process: CTTI Recommendations for Improved Informed Consent

NEW recommendations on Informed Consent

CTTI recommends a new model for the informed consent process that places the focus back where it should be: on the participant. The consent process should be an interactive, ongoing conversation between the participant and the research investigator or staff. “Patients who really understand what they are agreeing to when they sign an informed consent document are much more likely to adhere to trial requirements and be retained for the entire timeframe of the trial,” notes patient advocate, Jane Perlmutter. “Thus, not only is excellent consenting better for patients, it will also lead to more efficient and less costly trials.”

At a CTTI-hosted webinar on November 19, 2015, sponsors will hear suggestions and learn about tools to help them restructure the informed consent process and document to be more participant-friendly while retaining key information. The webinar will also explore the benefits of e-consent and how appropriate and thorough research staff training can improve the overall process for everyone involved.

The need for this new direction is recognized. “The Association of Clinical Research Professionals (ACRP) supports the recommendations put forth by our partners in the Clinical Trials Transformation Initiative,” says Jim Kremidas, ACRP Executive Director. “We are confident these recommendations will result in a more efficient and higher quality informed consent process conducted by clinical research professionals. A clear understanding of the risks and expectations clinical trial participants face will enhance their experience and drive better quality research.”

You’re Invited! CTTI Recommendations for an Improved Informed Consent Process to be Unveiled in November 19 Webinar

Join CTTI on November 19, 2015, as they host a webinar to present a new model of the informed consent process that places the focus back where it should be: the participant. This webinar will be the official unveiling of CTTI’s recommendations resulting from the Informed Consent Project and it is open to the public. We encourage you to share this invitation with your colleagues in the clinical trials enterprise.

Webinar Title: Public Unveiling of CTTI’s Informed Consent Project Recommendations

Date & Time: Thursday, November 19, 2015 from 12:00 – 1:00 p.m. EST

Speakers:

  • Jennifer Lentz, Global Informed Consent Process Owner, US CMS Coordinator, Global Clinical Operations, Eli Lilly and Company
  • Michele Kennett, Assistant Vice Chancellor for Research, Director of Human Research Protections, Director of MU Institutional Review Board, University of Missouri

Webinar Login:

  • CLICK HERE to enter meeting.
  • Meeting Number: 732 884 847
  • Meeting Password: ctti
  • After you connect to the website, please follow step-by-step instructions for connecting to the audio.
  • If you prefer to connect to audio only, you can join by phone at:
    • 1-855-244-8681 Call-in toll-free number (US/Canada)
    • 1-650-479-3207 Call-in toll number (US/Canada)

Recently Released: Expert Meeting Summary on IND Safety

On July 21 – 22, 2015, CTTI’s IND Safety Advancement Project hosted an expert meeting. The objectives of this multi-stakeholder meeting were to:

  • Present findings and conclusions from the project evidence gathering activities
  • Discuss opportunities for improving the efficiency and value of the expedited IND safety reporting process
  • Understand opportunities for educating stakeholders on expedited IND safety reporting best practices

The summary is now available online.

Recently Released: Expert Meeting Summary on DMC’s

On July 28 – 29, 2015, CTTI’s Data Monitoring Committee Project hosted an expert meeting. The objectives of this multi-stakeholder meeting were to:

  • Present findings and conclusions from the project survey and focus groups
  • Share and solicit feedback on proposed Data Monitoring Committees (DMCs) recommendations

The summary is now available online.

CTTI’s Recommendations & Implementation Tools for Advancing the Use of Central IRBs to be Featured in Upcoming MDICx Webinar

CTTI’s recommendations and implementation tools for advancing the use of central IRBs for multi-center clinical trials will be presented at the next webinar in the MDICx series. The featured speakers include Cynthia Hahn, Chief Operating Officer, The Feinstein Institute for Medical Research, and Soo Bang, Sr. Director, Global Alliances & Business Development, Celgene Corporation.

Webinar Details:

  • Date: Wednesday, August 12th
  • Time: 12:00 p.m. – 1:00 p.m. ET
  • REGISTER HERE

We look forward to this event and encourage the sharing of this invitation with colleagues involved in the clinical trial enterprise.

Recording Now Available: NIH Collaboratory Grand Rounds Features CTTI’s Central IRB Recommendations

On July 10, 2015, the NIH Collaboratory’s Grand Rounds Webinar Series featured the work of CTTI’s Central IRB Advancement Project. Co-team leader Cynthia Hahn reviewed the recently released recommendations for advancing the use of central IRBs for multicenter clinical trials.

We are now pleased to share the recording of this webinar:

CTTI’s IND Safety Advancement Project Presents at 7th Annual AACI Conference

On July 8-9, 2015, the Association of American Cancer Institutes (AACI) will host their 7th Annual AACI Clinical Research Initiative Meeting in Chicago. The results of CTTI’s IND Safety Advancement Project survey and interviews will be featured in the session titled, How Do Cancer Centers Ensure Patient Safety when Conducting Clinical Trials? The goal of this CTTI project is to increase compliance with respect to assessment, communication, review, and management of expedited IND safety reports. We look forward to this opportunity to share our work with colleagues.

Are you interested in safety reporting in clinical trials? Click here to read CTTI’s recommendations that resulted from our original IND Safety Project.

NIH Collaboratory Grand Rounds to Feature CTTI’s Central IRB Recommendations

On July 10, 2015, the NIH Collaboratory’s Grand Rounds Webinar Series will feature the work of CTTI’s Central IRB Advancement Project. Co-team leader Cynthia Hahn will review the recently released recommendations for advancing the use of central IRBs for multicenter clinical trials. We look forward to this opportunity to connect with colleagues and share the results of this project. Please forward this invitation with others interested in clinical triahttps://ctti-clinicaltrials.org/our-work/ethics-andl conduct.

Topic: The Clinical Trials Transformation Initiative’s (CTTI) Recommendations: Advancing the use of central IRBs for multicenter clinical trials

Date: Friday, July 10, 2015

Time: 1:00-2:00 p.m. ET

Speaker: Cynthia Hahn, Vice President, Clinical Research & Regulatory Affairs at North Shore-LIJ Health System, Chief Operating Officer, The Feinstein Institute for Medical Research

Meeting Link:
https://dukemed.webex.com/dukemed/j.php?MTID=m1a4a0665a615ae0382440edecedbdd33

For Audio ONLY:
Call-in toll-free number (US/Canada): 1-855-244-8681
Access code: 739 348 059

For additional webinar details, visit the NIH Collaboratory’s Grand Rounds calendar.

This is the first part of a webinar series co-hosted by the NIH Collaboratory and PCORnet, titled “A Grand Rounds Special Series: Use of Central IRBs for Multicenter Research.”